Zenas BioPharma logo

Director, HCP Marketing, Obexelimab

Zenas BioPharma

Waltham, MAOnsitePosted 1 day ago$192,800 - $241,000/year
Full TimeDirector & AboveCommercial & Pharma SalesBiotechnology
Original posting ↗

Summary

Zenas is seeking a collaborative, launch-experienced marketing leader to serve as the strategic brand leader for obexelimab among HCP audiences, including its first anticipated indication in IgG4-Related Disease (IgG4-RD). The Director, HCP Marketing will define and execute the HCP marketing strategy, ensuring the brand is optimally promoted from pre-launch through sustained post-launch performance.

Job description

Position Summary

Zenas is seeking a collaborative, launch-experienced marketing leader to serve as the strategic brand leader for obexelimab among HCP audiences, including its first anticipated indication in IgG4-Related Disease (IgG4-RD). The Director, HCP Marketing will define and execute the HCP marketing strategy, ensuring the brand is optimally promoted from pre-launch through sustained post-launch performance.

This leader will partner closely with Sales, Strategic Engagement, Sales Operations, Commercial Training, and agency partners to convert customer insights into differentiated messaging, high-quality promotional assets and aligned, compliant execution. The role will also help build the marketing capabilities Zenas requires as it transitions into a fully commercial organization.

Key Responsibilities

  • Lead the HCP marketing strategy for obexelimab, including segmentation, belief ladders and the messaging platform, in alignment with the brand strategy and the cross-functional launch plan
  • Develop and execute disease state education and branded HCP campaigns, including creative and messaging, from pre-launch through launch and post-launch
  • Lead tactical execution of personal and non-personal promotion within the HCP scope, partnering with the Director of Patient and Nurse Marketing as well as the Senior Director of Brand Experience and Engagement to ensure alignment across scopes
  • Define and execute the peer-to-peer programming plan, working with Strategic Engagement and marketing operations to deliver programs on time and in compliance
  • Lead HCP congress strategy and the execution of associated tactics
  • Guide agency partners day to day with clear briefs, timelines and budgets, prioritizing work based on business impact and available resources to deliver high-quality output on time and within budget
  • Partner with Sales, Sales Operations, Commercial Training, and Strategic Engagement working with a one-team mindset to remove barriers and ensure tools and resources are practical, compliant, insight-driven and aligned to the brand strategy
  • Track HCP-audience performance after launch, communicate results to cross-functional leaders and pivot strategy and tactics quickly when business needs require

Qualifications

Required

  • Bachelor's degree required; advanced degree in business, marketing or life sciences preferred
  • 8+ years of pharmaceutical or biotechnology commercial experience, including brand marketing experience pre- and post-launch
  • Deep understanding of US market dynamics, commercialization, pre-launch planning and cross-functional launch readiness
  • HCP marketing experience, including peer-to-peer programming and medical congress strategy
  • Familiarity with Veeva Vault PromoMats or equivalent promotional review platforms
  • Strong project management skills with the ability to manage multiple high-priority workstreams and meet tight deadlines
  • Demonstrated track record of agency management and building alignment across cross-functional stakeholders
  • Experience navigating MLR review processes and working closely with Legal, Regulatory, Compliance and Medical Affairs partners
  • Ability to travel up to approximately 20-25%, including national medical congresses, customer engagements, agency meetings and internal team meetings

Preferred

  • Immunology, inflammation and/or rare disease experience
  • Experience with rheumatology, gastroenterology, systemic autoimmune disease or B-cell mediated conditions
  • Field experience or close partnership with Sales and other customer-facing teams

Requirements

  • Bachelor's degree required
  • 8+ years of pharmaceutical or biotechnology commercial experience
  • Brand marketing experience pre- and post-launch
  • Deep understanding of US market dynamics, commercialization, pre-launch planning and cross-functional launch readiness
  • HCP marketing experience, including peer-to-peer programming and medical congress strategy
  • Familiarity with Veeva Vault PromoMats or equivalent promotional review platforms
  • Strong project management skills
  • Demonstrated track record of agency management and building alignment across cross-functional stakeholders
  • Experience navigating MLR review processes and working with Legal, Regulatory, Compliance and Medical Affairs partners
  • Ability to travel up to approximately 20-25%

Benefits

  • Annual performance bonus
  • Equity
  • Full range of benefits
  • Incentive compensation plans

Company overview

Zenas BioPharma (Nasdaq: ZBIO) is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients with autoimmune diseases. Founded with headquarters in Waltham, Massachusetts and additional operations in Shanghai, China, the company employs 51-200 professionals dedicated to advancing innovative treatments for autoimmune conditions. Zenas' core strategy combines an experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire, and develop promising therapies globally. The company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb to inhibit the activity of B cells implicated in autoimmune diseases without depleting them. Zenas is also advancing orelabrutinib, a BTK inhibitor, in clinical trials for multiple sclerosis. The company has reported positive Phase 3 results for IgG4-Related Disease and is progressing through late-stage clinical development for multiple autoimmune conditions, positioning itself as a significant player in the autoimmune therapeutics space.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.